INTERNATIONAL PATENT: GENESIS THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS OF TREATING SKP2-ASSOCIATED CANCERS"

GENEVA, Feb. 4 -- GENESIS THERAPEUTICS, INC. (1440 Chapin AvenueSuite 385Burlingame, California 94010) filed a patent application (PCT/US2025/038583) for "METHODS OF TREATING SKP2-ASSOCIATED CANCERS" on Jul 22, 2025. With publication no. WO/2026/024674, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DANN, Stephen George (1440 Chapin AvenueSuite 385Burlingame, California 94010)

Abstract: The present application relates to methods of treating SKP2-associate cancers, as defined herein, by administering one or more CDK2 inh...